For the structured discussion, the panel was divided into subgroups according to the major themes of this article: (a) treatment options and glycemic targets, (b) insulin regimens, (c) diabetes with cardiovascular disease, and (d) diabetic kidney disease. This evidence concerns the gene INS and diabetes mellitus.